INVIVYD INC (IVVD) Stock Price, Quote, News and Overview
NASDAQ:IVVD - Nasdaq - US00534A1025 - Common Stock - Currency: USD
IVVD Quote, Performance and Key Statistics
0.51
+0.04 (+8.21%)
The current stock price of IVVD is 0.51 USD. In the past month the price decreased by -30.95%. In the past year, price decreased by -77.83%.
IVVD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.09 | 306.02B | ||
| AMGN | AMGEN INC | 13.99 | 149.08B | ||
| GILD | GILEAD SCIENCES INC | 22.68 | 130.32B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1686.55 | 125.74B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.34 | 61.56B | ||
| ARGX | ARGENX SE - ADR | 318.82 | 36.23B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 30.51B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.88B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.74B | ||
| NTRA | NATERA INC | N/A | 20.02B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 18.15B | ||
| BIIB | BIOGEN INC | 7.2 | 17.36B |
Related stock screener links
About IVVD
Company Profile
Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is headquartered in Waltham, Massachusetts and currently employs 94 full-time employees. The company went IPO on 2021-08-06. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The firm delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2 (COVID-19). Its PEMGARDA is the Company’s first mAb in a planned series of innovative mAb candidates designed to keep pace with SARS-CoV-2 viral evolution. Its VYD2311 is optimized for neutralization potency against recent SARS-CoV-2 lineages such as BA.2.86 and JN.1. The firm also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.
Company Info
INVIVYD INC
1601 Trapelo Road, Suite 178
Waltham MASSACHUSETTS US
Employees: 95
Company Website: https://invivyd.com/
Investor Relations: https://investors.invivyd.com/
Phone: 17818190080
INVIVYD INC / IVVD FAQ
What is the stock price of INVIVYD INC today?
The current stock price of IVVD is 0.51 USD. The price increased by 8.21% in the last trading session.
What is the ticker symbol for INVIVYD INC stock?
The exchange symbol of INVIVYD INC is IVVD and it is listed on the Nasdaq exchange.
On which exchange is IVVD stock listed?
IVVD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for INVIVYD INC stock?
9 analysts have analysed IVVD and the average price target is 6.73 USD. This implies a price increase of 1220% is expected in the next year compared to the current price of 0.51. Check the INVIVYD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INVIVYD INC worth?
INVIVYD INC (IVVD) has a market capitalization of 61.18M USD. This makes IVVD a Micro Cap stock.
How many employees does INVIVYD INC have?
INVIVYD INC (IVVD) currently has 95 employees.
What are the support and resistance levels for INVIVYD INC (IVVD) stock?
INVIVYD INC (IVVD) has a support level at 0.47 and a resistance level at 0.55. Check the full technical report for a detailed analysis of IVVD support and resistance levels.
Is INVIVYD INC (IVVD) expected to grow?
The Revenue of INVIVYD INC (IVVD) is expected to grow by 599.08% in the next year. Check the estimates tab for more information on the IVVD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INVIVYD INC (IVVD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IVVD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IVVD, evaluating the profitability, health, valuation and growth aspects
- INVIVYD INC (IVVD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INVIVYD INC (IVVD) Sales and EPS estimates to see what analysts future expectations are.
- INVIVYD INC (IVVD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INVIVYD INC (IVVD) Insider and Institutional Ownership to learn about the owners and their transactions.
- INVIVYD INC (IVVD) Stock Chart to make your own analysis
- INVIVYD INC (IVVD) Latest news and press-releases to stay up to date.
Does INVIVYD INC (IVVD) stock pay dividends?
IVVD does not pay a dividend.
When does INVIVYD INC (IVVD) report earnings?
INVIVYD INC (IVVD) will report earnings on 2025-05-09, after the market close.
What is the Price/Earnings (PE) ratio of INVIVYD INC (IVVD)?
INVIVYD INC (IVVD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.49).
What is the Short Interest ratio of INVIVYD INC (IVVD) stock?
The outstanding short interest for INVIVYD INC (IVVD) is 9.67% of its float. Check the ownership tab for more information on the IVVD short interest.
IVVD Technical Analysis
IVVD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to IVVD. The financial health of IVVD is average, but there are quite some concerns on its profitability.
IVVD Financial Highlights
Over the last trailing twelve months IVVD reported a non-GAAP Earnings per Share(EPS) of -1.49. The EPS increased by 17.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -131.2% | ||
| ROE | -251.59% | ||
| Debt/Equity | 0 |
IVVD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to IVVD. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 107.76% and a revenue growth 599.08% for IVVD